Fresenius Kabi USA

Hear from Paul Stranges, Assistant Director of Opioid Stewardship and Drug Diversion at UI Health, as he explains how the transition to lower-dose controlled substances improved productivity for nursing and diversion teams. Watch the video ➡️ https://bit.ly/4wxEo0c. #FreseniusCommittedToLife #Simplist #ReadyToAdminister

Refeeding syndrome reflects a rapid metabolic shift. As the body transitions from starvation to refeeding, electrolyte imbalances can occur and may lead to serious complications if not managed appropriately. Our latest blog outlines the American Society for Parenteral and Enteral Nutrition (ASPEN) consensus recommendations for refeeding syndrome and parenteral nutrition initiation, with a focus on screening, cautious advancement, and close monitoring. Read more: https://bit.ly/3N0yEVP #FreseniusCommittedToLife #MedicalNutrition Sources: 1. da Silva JSV, Seres DS, Sabino K, et al. ASPEN Consensus Recommendations for Refeeding Syndrome. Nutr Clin Pract. 2020;35(2):178-195. 2. Woo Ha S, Hong S-K. Recent advances in refeeding syndrome in critically ill patients: a narrative review. Ann Clin Nutr Metab. 2024;16:3-9. 3. Borriello R, Esposto G, Ainora ME, et al. Understanding Refeeding Syndrome in Critically Ill Patients: A Narrative Review. Nutrients. 2025;17:1866.

Latorra Garland turned grief into advocacy. In her son Jacob’s memory, she donates blood, speaks at events, and founded Jacob Way to support families fighting childhood cancer. 👉 www.BloodDonorHOF.com Carter BloodCare #FreseniusCommittedToLife #BloodDonation #TeamFresenius

Global reach. Advanced sterile manufacturing capabilities. Fresenius Kabi Contract Manufacturing provides access to a network of 17+ development and manufacturing facilities for sterile pharmaceuticals worldwide. Across our three U.S. manufacturing sites, we offer vial, IV bag and prefilled syringe fill-finish capabilities, including FDA-approved high potency and cytotoxic isolator filling lines. Our teams work closely with customers to identify the right technology and production approach for their products. Explore our capabilities: cmo.fresenius-kabi.com #ContractManufacturing #FocusedOnYourSuccess

"True resilience comes from the experience, preparedness, and judgment of the people who know how to activate those resources when it matters most.” – Angie Lindsey, Vice President, Marketing. ARTICLE: How Fresenius Kabi Helped Stabilize the U.S. Heparin Supply https://bit.ly/4uft5JG. Over the past two decades, the U.S. heparin supply has faced serious problems. Each time, Fresenius Kabi stepped in to help support supply. It’s one more example of how our “More in America” commitment supports continuity of care. #FutureFresenius #FreseniusCommittedToLife #Healthcare #MoreInAmerica

Intended for US audiences only. A decade of providing more options to more adult patients. To learn more about SMOFlipid or our portfolio of clinical nutrition products, visit: https://bit.ly/4z0AGyw. SMOFlipid® (lipid injectable emulsion), for intravenous use MPORTANT SAFETY INFORMATION SMOFlipid is indicated in adult and pediatric patients as a source of calories and essential fatty acids for parenteral nutrition (PN) when oral or enteral nutrition is not possible, insufficient, or contraindicated. Should not be received by patients who have a known allergy to fish, egg, soybean, or peanut, or any of the ingredients or abnormally high levels of lipid (triglycerides) in the blood. May cause serious side effects, including death, with rapid infusion of intravenous lipid emulsion in neonates and infants, risk of parenteral nutrition-associated liver disease, allergic reactions, fat overload syndrome, refeeding syndrome and elevated triglyceride levels. Contact your healthcare provider to learn more. For a more complete overview of the full risk profile, visit: https://bit.ly/4byiy55. #FreseniusCommittedToLife #MedicalNutrition

Mount Sinai Medical Center in Miami Beach is taking an important step forward in IV therapy.    The medical center has gone live with multiple products from Fresenius Kabi’s comprehensive IV therapy portfolio, including more than 1,800 Ivenix infusion pumps, IV solutions, and non-dedicated sets.    This milestone also includes integration of the Ivenix Infusion System with Real-Time Location Services (RTLS), using RFID technology to help care teams more easily track and locate pumps. They are also planning to integrate with their EMR to allow for auto-programming and auto-documentation.     Together, these capabilities reflect a shared commitment to innovation and can help reduce time spent managing equipment so clinicians can focus their time on patient care.    We look forward to continuing our collaboration with the Mount Sinai team to support high-quality patient care.     #FreseniusCommittedToLife #FutureFresenius #Ivenix #IVTherapy

This post is intended for U.S. audiences only. The FDA has approved Fresenius Kabi's latest biosimilar, further strengthening our growing biosimilars portfolio. This milestone represents another step forward in our efforts to expand access to biologic medicines in the U.S. Read the full announcement: https://bit.ly/4gbdMgp #Fresenius #CommittedToLife

Happy #NationalInternDay to our amazing summer interns!   This summer, our interns brought fresh ideas, a strong sense of purpose and an eagerness to learn that enriched our teams and strengthened our Committed to Life purpose.  We spoke with a few interns about their internship experience, including opportunities to explore diverse career paths and connect with mentors across the organization. Through hands-on projects and professional development opportunities, they developed valuable skills that will serve them well in the future.  To all our interns: thank you for your hard work, your ideas and the positive energy you bring with you every day. We are proud to have been a part of your early career journey and can't wait to see your future successes! #Fresenius #CommittedToLife #Internships #TeamFresenius

When prescribing parenteral nutrition (PN), formulation is only part of the equation. Infusion modality—continuous vs. intermittent—may influence glycemic control, infection risk, liver function, and patient quality of life. Our latest blog breaks down the evidence and highlights why PN delivery should be tailored to each patient. Read more: https://lnkd.in/edE7TzYy #Fresenius #CommitedToLife #ParenteralNutrition #MedicalNutrition Sources: 1. Zhou Z, Zhou J. Eur J Clin Nutr. 2026;80(2):140-145. 2. Stout SM, Cober MP. Pract Gastroenterol. 2011;July:11-24.